Literature DB >> 16319655

Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus.

Gregg D Simonson1, David M Kendall.   

Abstract

Insulin resistance is a common underlying physiologic abnormality associated with central obesity, type 2 diabetes and cardiovascular disease. Clinically, its hallmark markers of hypertension, glucose intolerance and dyslipidemia have been grouped into associated syndromes of insulin resistance. Insulin resistance is now considered a useful marker of clinical risk and a target for therapeutic intervention. While the criteria for diagnosis of syndromes related to insulin resistance have been established, the clinical diagnosis of insulin resistance remains a significant challenge. As more clinicians focus on the management of insulin resistance in patients with cardiovascular disease, type 2 diabetes and other syndromes of insulin resistance, its diagnosis will take on increasing importance. This review focuses on the current definition and diagnosis of insulin resistance and associated syndromes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16319655     DOI: 10.1097/00019501-200512000-00002

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  8 in total

1.  Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.

Authors:  Mahsa Eskian; Abass Alavi; MirHojjat Khorasanizadeh; Benjamin L Viglianti; Hans Jacobsson; Tara D Barwick; Alipasha Meysamie; Sun K Yi; Shingo Iwano; Bohdan Bybel; Federico Caobelli; Filippo Lococo; Joaquim Gea; Antonio Sancho-Muñoz; Jukka Schildt; Ebru Tatcı; Constantin Lapa; Georgia Keramida; Michael Peters; Raef R Boktor; Joemon John; Alexander G Pitman; Tomasz Mazurek; Nima Rezaei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-22       Impact factor: 9.236

2.  Associations of complete blood count parameters with pancreatic beta-cell function and insulin resistance in prediabetes and type 2 diabetes mellitus.

Authors:  Eun-Hee Nah; Seon Cho; Hyeran Park; Suyoung Kim; Han-Ik Cho
Journal:  J Clin Lab Anal       Date:  2022-05-13       Impact factor: 3.124

3.  A neural signature of metabolic syndrome.

Authors:  Eithan Kotkowski; Larry R Price; Crystal Franklin; Maximino Salazar; Mary Woolsey; Ralph A DeFronzo; John Blangero; David C Glahn; Peter T Fox
Journal:  Hum Brain Mapp       Date:  2019-05-07       Impact factor: 5.038

4.  Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway.

Authors:  Aili Aierken; Balun Li; Peng Liu; Xuedi Cheng; Zheng Kou; Ning Tan; Mengfei Zhang; Shuai Yu; Qiaoyan Shen; Xiaomin Du; Bold Bayar Enkhbaatar; Juqing Zhang; Rui Zhang; Xiaolong Wu; Ruibin Wang; Xin He; Na Li; Sha Peng; Wenwen Jia; Congrong Wang; Jinlian Hua
Journal:  Stem Cell Res Ther       Date:  2022-04-12       Impact factor: 6.832

5.  Associations of Serum Total 25OHD, 25OHD3, and epi-25OHD3 with Insulin Resistance: Cross-Sectional Analysis of the National Health and Nutrition Examination Survey, 2011-2016.

Authors:  Meiling Zhou; Ruixue Huang
Journal:  Nutrients       Date:  2022-08-26       Impact factor: 6.706

6.  The usefulness of the estimated average glucose/fasting blood glucose ratio for pancreatic β-cell function assessment in hyperglycemia during health checkups.

Authors:  Eun-Hee Nah; Seon Cho; Hyeran Park; Suyoung Kim; Eunjoo Kwon; Han-Ik Cho
Journal:  J Clin Lab Anal       Date:  2022-09-13       Impact factor: 3.124

7.  Hypoglycemic effect of Chlorella vulgaris intake in type 2 diabetic Goto-Kakizaki and normal Wistar rats.

Authors:  Hyejin Jeong; Hye Jin Kwon; Mi Kyung Kim
Journal:  Nutr Res Pract       Date:  2009-03-31       Impact factor: 1.926

Review 8.  Assessment of pancreatic β-cell function: review of methods and clinical applications.

Authors:  Eugenio Cersosimo; Carolina Solis-Herrera; Michael E Trautmann; Jaret Malloy; Curtis L Triplitt
Journal:  Curr Diabetes Rev       Date:  2014-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.